Sort
51,593 grants matching “hepatitis”
Noninvasive urinary monitoring of NASH by activity-based nanosensors
$555,976Eric Kai Huang · Glympse Bio, Inc. · R44 · FY2018 · DK
Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD
$555,961Jennifer R Havens · University Of Kentucky · R01 · FY2017 · DA
Role of heat shock transcription factor HSF1 in tumorigenesis
$555,929Nahid F Mivechi · Augusta University · R01 · FY2020 · CA
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$555,896Mark A Kay · Stanford University · R01 · FY2018 · HL
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$555,833Patrice Mimche · Indiana University Indianapolis · R01 · FY2025 · DK
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
$555,764Tuoqi Wu · Ut Southwestern Medical Center · R01 · FY2025 · AI
Engineering microcapsules for scalable differentiation of human pluripotent stem cells into hepatocytes
$555,713Alexander Revzin · Mayo Clinic Rochester · R01 · FY2025 · DK
Neutralizing Antibodies to Hepatitis C
$555,699Stanford University · R01 · FY2005 · HL
Modeling Epidemic Infectious Diseases Using Sequence Analysis
$555,642Sergei L Kosakovsky Pond · Temple Univ Of The Commonwealth · U01 · FY2016 · GM
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
$555,637Craig Lewis Duvall · Vanderbilt University · R01 · FY2023 · CA
Drug Phosphorylation and Aging
$555,596Benjamin Carl Orsburn · Johns Hopkins University · R01 · FY2022 · AG
Drug Phosphorylation and Aging
$555,596Namandje N Bumpus · Johns Hopkins University · R01 · FY2021 · AG
Drug Phosphorylation and Aging
$555,596Namandje N Bumpus · Johns Hopkins University · R01 · FY2020 · AG
A multi-modular approach for human pluripotent stem cell-based liver regeneration
$555,521Valerie B Gouon-Evans · Boston Medical Center · R01 · FY2020 · DK
Transcriptional and non-transcriptional function of IRF3 in ALD
$555,449Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AA
Liver Disease and HIV-HBV Coinfection in the HAART era
$555,332Chloe L Thio · Johns Hopkins University · R01 · FY2006 · AI
Multi-modality detection of RCC Recurrence Post Ablation
$555,321John Eisenbrey · Thomas Jefferson University · R01 · FY2024 · CA
Mechanisms of antibody-mediated control of repeated hepatitis C virus infection in humans
$555,279Justin Richard Bailey · Johns Hopkins University · U19 · FY2023 · AI
Influence of Heme on Hepatic Cytochrome P450 Turnover
$555,260Maria Almira Correia · University Of California, San Francisco · R01 · FY2015 · DK
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
$555,213Mark A Kay · Stanford University · R01 · FY2011 · HL
HIV and Other Infectious Consequences of Substance Use
$555,196Josiah D Rich · Miriam Hospital · T32 · FY2025 · DA
Understanding B cell memory in response to diverse virus infections
$555,183Michel C Nussenzweig · Rockefeller University · U19 · FY2023 · AI
The Environment as a Variable to Calibrate Mouse Models of Human Disease
$555,180John M Essigmann · Massachusetts Institute Of Technology · R01 · FY2009 · ES
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
$555,172Mikhail Nikiforov · Duke University · R01 · FY2023 · CA
Synthetic Cannabinoid Toxicity: Role of Biotransformation
$555,072Paul L Prather · Univ Of Arkansas For Med Scis · R01 · FY2020 · DA